Hang Lung Group Limited Logo

Hang Lung Group Limited

0010.HK

(2.2)
Stock Price

9,99 HKD

0.87% ROA

2.12% ROE

7.08x PER

Market Cap.

14.242.545.200,00 HKD

56.08% DER

8.22% Yield

17% NPM

Hang Lung Group Limited Stock Analysis

Hang Lung Group Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Hang Lung Group Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.16x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a low debt to equity ratio (50%), which means it has a small amount of debt compared to the ownership it holds

3 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

4 ROE

The stock's ROE falls within an average range (2.52%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (1.02%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

6 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

7 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

9 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

10 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (5), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Hang Lung Group Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Hang Lung Group Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Hang Lung Group Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Hang Lung Group Limited Revenue
Year Revenue Growth
1993 5.464.100.000
1994 5.147.200.000 -6.16%
1995 6.938.900.000 25.82%
1996 7.359.000.000 5.71%
1997 5.229.900.000 -40.71%
1998 3.525.200.000 -48.36%
1999 2.821.800.000 -24.93%
2000 5.823.400.000 51.54%
2001 3.254.000.000 -78.96%
2002 3.421.400.000 4.89%
2003 5.449.300.000 37.21%
2004 7.472.200.000 27.07%
2005 4.283.700.000 -74.43%
2006 4.777.800.000 10.34%
2007 10.553.100.000 54.73%
2008 4.696.400.000 -124.71%
2009 12.580.000.000 62.67%
2010 5.714.000.000 -120.16%
2011 3.361.000.000 -70.01%
2012 7.986.000.000 57.91%
2013 10.165.000.000 21.44%
2014 17.961.000.000 43.41%
2015 9.784.000.000 -83.58%
2016 13.777.000.000 28.98%
2017 11.995.000.000 -14.86%
2018 10.015.000.000 -19.77%
2019 9.449.000.000 -5.99%
2020 9.556.000.000 1.12%
2021 10.933.000.000 12.59%
2022 10.935.000.000 0.02%
2023 10.878.000.000 -0.52%
2024 26.044.000.000 58.23%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Hang Lung Group Limited Research and Development Expenses
Year Research and Development Expenses Growth
1993 0
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 1 0%
2017 1 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Hang Lung Group Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1993 0
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 136.700.000 100%
2000 148.200.000 7.76%
2001 164.500.000 9.91%
2002 127.900.000 -28.62%
2003 181.700.000 29.61%
2004 175.100.000 -3.77%
2005 252.000.000 30.52%
2006 328.500.000 23.29%
2007 450.100.000 27.02%
2008 448.800.000 -0.29%
2009 526.000.000 14.68%
2010 490.000.000 -7.35%
2011 300.000.000 -63.33%
2012 695.000.000 56.83%
2013 698.000.000 0.43%
2014 705.000.000 0.99%
2015 728.000.000 3.16%
2016 671.000.000 -8.49%
2017 656.000.000 -2.29%
2018 707.000.000 7.21%
2019 623.000.000 -13.48%
2020 559.000.000 -11.45%
2021 618.000.000 9.55%
2022 673.000.000 8.17%
2023 680.000.000 1.03%
2024 1.384.000.000 50.87%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Hang Lung Group Limited EBITDA
Year EBITDA Growth
1993 5.464.100.000
1994 5.147.200.000 -6.16%
1995 6.938.900.000 25.82%
1996 7.359.000.000 5.71%
1997 5.229.900.000 -40.71%
1998 3.525.200.000 -48.36%
1999 2.104.200.000 -67.53%
2000 2.162.500.000 2.7%
2001 1.638.400.000 -31.99%
2002 1.466.500.000 -11.72%
2003 2.435.000.000 39.77%
2004 3.454.000.000 29.5%
2005 2.371.600.000 -45.64%
2006 2.633.400.000 9.94%
2007 17.997.600.000 85.37%
2008 7.371.500.000 -144.15%
2009 30.781.000.000 76.05%
2010 8.159.000.000 -277.26%
2011 3.782.000.000 -115.73%
2012 11.735.000.000 67.77%
2013 -862.000.000 1461.37%
2014 -3.865.000.000 77.7%
2015 -2.056.000.000 -87.99%
2016 -3.611.000.000 43.06%
2017 -1.113.000.000 -224.44%
2018 -326.000.000 -241.41%
2019 3.304.000.000 109.87%
2020 6.399.000.000 48.37%
2021 3.730.000.000 -71.55%
2022 3.931.000.000 5.11%
2023 7.199.000.000 45.4%
2024 -7.048.000.000 202.14%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Hang Lung Group Limited Gross Profit
Year Gross Profit Growth
1993 5.464.100.000
1994 5.147.200.000 -6.16%
1995 6.938.900.000 25.82%
1996 7.359.000.000 5.71%
1997 5.229.900.000 -40.71%
1998 3.525.200.000 -48.36%
1999 2.821.800.000 -24.93%
2000 5.823.400.000 51.54%
2001 3.254.000.000 -78.96%
2002 3.421.400.000 4.89%
2003 5.449.300.000 37.21%
2004 7.472.200.000 27.07%
2005 4.283.700.000 -74.43%
2006 4.777.800.000 10.34%
2007 6.773.000.000 29.46%
2008 3.816.000.000 -77.49%
2009 9.352.000.000 59.2%
2010 4.576.000.000 -104.37%
2011 2.653.000.000 -72.48%
2012 6.160.000.000 56.93%
2013 10.165.000.000 39.4%
2014 13.761.000.000 26.13%
2015 7.211.000.000 -90.83%
2016 9.467.000.000 23.83%
2017 8.533.000.000 -10.95%
2018 7.249.000.000 -17.71%
2019 6.912.000.000 -4.88%
2020 6.910.000.000 -0.03%
2021 7.821.000.000 11.65%
2022 7.677.000.000 -1.88%
2023 7.791.000.000 1.46%
2024 14.980.000.000 47.99%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Hang Lung Group Limited Net Profit
Year Net Profit Growth
1993 2.020.900.000
1994 2.160.000.000 6.44%
1995 2.275.200.000 5.06%
1996 2.520.000.000 9.71%
1997 1.029.100.000 -144.87%
1998 1.265.400.000 18.67%
1999 873.100.000 -44.93%
2000 1.416.300.000 38.35%
2001 691.800.000 -104.73%
2002 488.000.000 -41.76%
2003 986.600.000 50.54%
2004 8.282.300.000 88.09%
2005 2.832.600.000 -192.39%
2006 8.592.100.000 67.03%
2007 7.516.300.000 -14.31%
2008 2.637.900.000 -184.93%
2009 12.404.000.000 78.73%
2010 3.529.000.000 -251.49%
2011 1.578.000.000 -123.64%
2012 5.262.000.000 70.01%
2013 4.557.000.000 -15.47%
2014 6.825.000.000 33.23%
2015 3.211.000.000 -112.55%
2016 3.713.000.000 13.52%
2017 5.314.000.000 30.13%
2018 5.285.000.000 -0.55%
2019 6.816.000.000 22.46%
2020 -1.541.000.000 542.31%
2021 2.589.000.000 159.52%
2022 2.718.000.000 4.75%
2023 2.811.000.000 3.31%
2024 3.552.000.000 20.86%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Hang Lung Group Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1993 2
1994 2 0%
1995 2 0%
1996 2 0%
1997 1 0%
1998 1 0%
1999 1 0%
2000 1 0%
2001 1 0%
2002 0 0%
2003 2 100%
2004 4 66.67%
2005 2 -50%
2006 4 33.33%
2007 6 40%
2008 2 -400%
2009 10 88.89%
2010 3 -350%
2011 2 0%
2012 4 33.33%
2013 3 0%
2014 5 40%
2015 2 -150%
2016 3 0%
2017 4 33.33%
2018 4 0%
2019 5 40%
2020 -1 600%
2021 2 200%
2022 2 50%
2023 2 0%
2024 3 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Hang Lung Group Limited Free Cashflow
Year Free Cashflow Growth
1993 -4.377.800.000
1994 -2.107.100.000 -107.76%
1995 4.935.500.000 142.69%
1996 3.729.600.000 -32.33%
1997 439.200.000 -749.18%
1998 -1.456.600.000 130.15%
1999 108.000.000 1448.7%
2000 -2.619.700.000 104.12%
2001 55.000.000 4863.09%
2002 -220.500.000 124.94%
2003 252.700.000 187.26%
2004 3.933.000.000 93.57%
2005 549.600.000 -615.61%
2006 70.400.000 -680.68%
2007 6.538.700.000 98.92%
2008 1.184.600.000 -451.98%
2009 5.543.000.000 78.63%
2010 -1.419.000.000 490.63%
2011 -5.903.000.000 75.96%
2012 -210.000.000 -2710.95%
2013 -4.724.000.000 95.55%
2014 10.149.000.000 146.55%
2015 -189.000.000 5469.84%
2016 4.346.000.000 104.35%
2017 4.586.000.000 5.23%
2018 -6.910.000.000 166.37%
2019 -6.618.000.000 -4.41%
2020 -546.000.000 -1112.09%
2021 -1.135.000.000 51.89%
2022 378.000.000 400.26%
2023 -840.000.000 145%
2024 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Hang Lung Group Limited Operating Cashflow
Year Operating Cashflow Growth
1993 -683.400.000
1994 -334.300.000 -104.43%
1995 6.339.500.000 105.27%
1996 4.145.200.000 -52.94%
1997 1.966.100.000 -110.83%
1998 -585.100.000 436.03%
1999 1.707.800.000 134.26%
2000 -1.391.000.000 222.77%
2001 488.400.000 384.81%
2002 -48.600.000 1104.94%
2003 715.200.000 106.8%
2004 5.259.900.000 86.4%
2005 2.011.900.000 -161.44%
2006 2.944.400.000 31.67%
2007 7.987.100.000 63.14%
2008 3.451.800.000 -131.39%
2009 9.229.000.000 62.6%
2010 4.905.000.000 -88.15%
2011 1.057.000.000 -364.05%
2012 5.150.000.000 79.48%
2013 5.172.000.000 0.43%
2014 15.454.000.000 66.53%
2015 5.999.000.000 -157.61%
2016 7.028.000.000 14.64%
2017 8.837.000.000 20.47%
2018 6.104.000.000 -44.77%
2019 5.698.000.000 -7.13%
2020 2.579.000.000 -120.94%
2021 1.743.000.000 -47.96%
2022 3.099.000.000 43.76%
2023 2.292.000.000 -35.21%
2024 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Hang Lung Group Limited Capital Expenditure
Year Capital Expenditure Growth
1993 3.694.400.000
1994 1.772.800.000 -108.39%
1995 1.404.000.000 -26.27%
1996 415.600.000 -237.82%
1997 1.526.900.000 72.78%
1998 871.500.000 -75.2%
1999 1.599.800.000 45.52%
2000 1.228.700.000 -30.2%
2001 433.400.000 -183.5%
2002 171.900.000 -152.12%
2003 462.500.000 62.83%
2004 1.326.900.000 65.14%
2005 1.462.300.000 9.26%
2006 2.874.000.000 49.12%
2007 1.448.400.000 -98.43%
2008 2.267.200.000 36.12%
2009 3.686.000.000 38.49%
2010 6.324.000.000 41.71%
2011 6.960.000.000 9.14%
2012 5.360.000.000 -29.85%
2013 9.896.000.000 45.84%
2014 5.305.000.000 -86.54%
2015 6.188.000.000 14.27%
2016 2.682.000.000 -130.72%
2017 4.251.000.000 36.91%
2018 13.014.000.000 67.34%
2019 12.316.000.000 -5.67%
2020 3.125.000.000 -294.11%
2021 2.878.000.000 -8.58%
2022 2.721.000.000 -5.77%
2023 3.132.000.000 13.12%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Hang Lung Group Limited Equity
Year Equity Growth
1993 35.604.600.000
1994 37.501.400.000 5.06%
1995 39.478.300.000 5.01%
1996 47.011.300.000 16.02%
1997 36.457.700.000 -28.95%
1998 32.857.000.000 -10.96%
1999 19.292.300.000 -70.31%
2000 18.723.400.000 -3.04%
2001 32.381.200.000 42.18%
2002 29.526.400.000 -9.67%
2003 35.205.900.000 16.13%
2004 44.321.100.000 20.57%
2005 46.326.300.000 4.33%
2006 58.489.800.000 20.8%
2007 72.056.400.000 18.83%
2008 74.941.800.000 3.85%
2009 97.165.000.000 22.87%
2010 120.197.000.000 19.16%
2011 121.168.000.000 0.8%
2012 129.615.000.000 6.52%
2013 136.408.000.000 4.98%
2014 144.696.000.000 5.73%
2015 140.302.000.000 -3.13%
2016 138.013.000.000 -1.66%
2017 149.556.000.000 7.72%
2018 150.736.000.000 0.78%
2019 158.327.000.000 4.79%
2020 159.339.000.000 0.64%
2021 164.487.000.000 3.13%
2022 155.213.000.000 -5.98%
2023 154.916.000.000 -0.19%
2024 153.826.000.000 -0.71%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Hang Lung Group Limited Assets
Year Assets Growth
1993 47.483.600.000
1994 49.131.600.000 3.35%
1995 52.008.800.000 5.53%
1996 56.575.400.000 8.07%
1997 46.273.000.000 -22.26%
1998 45.806.000.000 -1.02%
1999 49.567.700.000 7.59%
2000 50.234.100.000 1.33%
2001 48.921.300.000 -2.68%
2002 46.496.800.000 -5.21%
2003 51.922.200.000 10.45%
2004 58.609.600.000 11.41%
2005 66.508.400.000 11.88%
2006 76.222.400.000 12.74%
2007 93.488.700.000 18.47%
2008 98.533.500.000 5.12%
2009 126.335.000.000 22.01%
2010 155.367.000.000 18.69%
2011 163.088.000.000 4.73%
2012 182.903.000.000 10.83%
2013 198.965.000.000 8.07%
2014 205.373.000.000 3.12%
2015 195.706.000.000 -4.94%
2016 186.369.000.000 -5.01%
2017 195.788.000.000 4.81%
2018 198.597.000.000 1.41%
2019 213.239.000.000 6.87%
2020 224.746.000.000 5.12%
2021 238.026.000.000 5.58%
2022 226.539.000.000 -5.07%
2023 231.452.000.000 2.12%
2024 232.691.000.000 0.53%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Hang Lung Group Limited Liabilities
Year Liabilities Growth
1993 11.879.000.000
1994 11.630.200.000 -2.14%
1995 12.530.500.000 7.18%
1996 9.564.100.000 -31.02%
1997 9.815.300.000 2.56%
1998 12.949.000.000 24.2%
1999 30.275.400.000 57.23%
2000 31.510.700.000 3.92%
2001 16.540.100.000 -90.51%
2002 16.970.400.000 2.54%
2003 16.716.300.000 -1.52%
2004 14.288.500.000 -16.99%
2005 20.182.100.000 29.2%
2006 17.732.600.000 -13.81%
2007 21.432.300.000 17.26%
2008 23.591.700.000 9.15%
2009 29.170.000.000 19.12%
2010 35.170.000.000 17.06%
2011 41.920.000.000 16.1%
2012 53.288.000.000 21.33%
2013 43.367.000.000 -22.88%
2014 32.158.000.000 -34.86%
2015 30.690.000.000 -4.78%
2016 30.551.000.000 -0.45%
2017 25.022.000.000 -22.1%
2018 27.291.000.000 8.31%
2019 27.872.000.000 2.08%
2020 65.407.000.000 57.39%
2021 73.539.000.000 11.06%
2022 71.326.000.000 -3.1%
2023 76.536.000.000 6.81%
2024 47.704.000.000 -60.44%

Hang Lung Group Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
8.68
Net Income per Share
1.48
Price to Earning Ratio
7.08x
Price To Sales Ratio
1.2x
POCF Ratio
18.95
PFCF Ratio
-12.76
Price to Book Ratio
0.15
EV to Sales
4.61
EV Over EBITDA
32.25
EV to Operating CashFlow
72.58
EV to FreeCashFlow
-49.04
Earnings Yield
0.14
FreeCashFlow Yield
-0.08
Market Cap
14,24 Bil.
Enterprise Value
54,73 Bil.
Graham Number
48.27
Graham NetNet
-27.47

Income Statement Metrics

Net Income per Share
1.48
Income Quality
0.37
ROE
0.02
Return On Assets
0.01
Return On Capital Employed
0.03
Net Income per EBT
0.4
EBT Per Ebit
0.74
Ebit per Revenue
0.58
Effective Tax Rate
0.31

Margins

Sales, General, & Administrative to Revenue
0.06
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.63
Operating Profit Margin
0.58
Pretax Profit Margin
0.43
Net Profit Margin
0.17

Dividends

Dividend Yield
0.08
Dividend Yield %
8.22
Payout Ratio
0.14
Dividend Per Share
0.86

Operating Metrics

Operating Cashflow per Share
0.55
Free CashFlow per Share
-0.82
Capex to Operating CashFlow
2.48
Capex to Revenue
0.16
Capex to Depreciation
44.52
Return on Invested Capital
0.03
Return on Tangible Assets
0.01
Days Sales Outstanding
121.17
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
3.01
Payables Turnover
0
Inventory Turnover
0
Capex per Share
1.37

Balance Sheet

Cash per Share
5,28
Book Value per Share
135,41
Tangible Book Value per Share
135.41
Shareholders Equity per Share
70.15
Interest Debt per Share
40.14
Debt to Equity
0.56
Debt to Assets
0.23
Net Debt to EBITDA
23.86
Current Ratio
1.2
Tangible Asset Value
184,99 Bil.
Net Current Asset Value
-40,49 Bil.
Invested Capital
202805000000
Working Capital
1,18 Bil.
Intangibles to Total Assets
0
Average Receivables
3,69 Bil.
Average Payables
5,07 Bil.
Average Inventory
7122000000
Debt to Market Cap
3.77

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Hang Lung Group Limited Dividends
Year Dividends Growth
2000 1
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 1 0%
2006 1 0%
2007 1 0%
2008 1 0%
2009 1 0%
2010 1 0%
2011 1 0%
2012 1 0%
2013 1 0%
2014 1 0%
2015 1 0%
2016 1 0%
2017 1 0%
2018 1 0%
2019 1 0%
2020 0 0%
2021 1 0%
2022 1 0%
2023 1 0%
2024 1 0%

Hang Lung Group Limited Profile

About Hang Lung Group Limited

Hang Lung Group Limited, an investment holding company, operates as a property developer in Hong Kong and Mainland China. The company operates through Property Leasing and Property Sales segments. It develops properties for sale and lease, such as large-scale commercial, office, and residential developments. The company also develops various properties, including shopping mall, office premises, residential and industrial premises, and carparking bays. Its investment properties portfolio includes Grand Gateway 66, a commercial, office, and residential complex, as well as Plaza 66, a commercial and office complex in Shanghai; Palace 66 and Forum 66 in Shenyang; Parc 66 in Jinan; Center 66 in Wuxi; Riverside 66 in Tianjin; Olympia 66 in Dalian; Spring City 66 in Kunming; Heartland 66 in Wuhan; and Westlake 66 in Hangzhou. In addition, the company offers car park and property management, financial, project management, dry and laundry cleaning, and property agency services, as well as operates and manages apartment. Hang Lung Group Limited was founded in 1960 and is headquartered in Central, Hong Kong.

CEO
Mr. Wai Pak Lo
Employee
4.141
Address
Standard Chartered Bank Building
Central,

Hang Lung Group Limited Executives & BODs

Hang Lung Group Limited Executives & BODs
# Name Age
1 Mr. Wai Pak Lo
Chief Executive Officer & Executive Director
70
2 Mr. Chuk Fai Kwan
Assistant Director - Corporate Communications
70
3 Mr. Wenbwo Chan
Executive Chair of the Board
70
4 Ms. Yuen Wah Ma
Director – General Counsel & Company Secretary
70
5 Mr. Ka Kui Chiu
Chief Financial Officer & Executive Director
70

Hang Lung Group Limited Competitors